Subject | Gender | Study eye | Age (years) | Prior Tx | Insulin | Hypertension | Hypercholesterolaemia | HbA1C | |
Intravitreal pegaptanib sodium | |||||||||
1 | Female | OD | 75 | No | No | Yes | No | 5.6 | |
2 | Male | OS | 51 | No | No | Yes | Yes | 8.4 | |
3 | Male | OD | 36 | No | Yes | Yes | No | 5.4 | |
4 | Male | OD | 55 | No | No | Yes | Yes | 7.6 | |
5 | Male | OS | 59 | No | No | No | Yes | 7.6 | |
6 | Female | OD | 61 | No | No | Yes | Yes | 8.5 | |
7 | Male | OS | 54 | No | No | No | Yes | 6.5 | |
8 | Female | OD | 54 | No | No | No | Yes | 6.9 | |
9 | Female | OS | 62 | IVT | Yes | No | No | 10.7 | |
10 | Male | OD | 55 | PRP | No | Yes | Yes | 6.9 | |
Panretinal photocoagulation | |||||||||
11 | Male | OS | 69 | No | Yes | Yes | Yes | 9.2 | |
12 | Female | OD | 49 | No | No | Yes | Yes | 10.4 | |
13 | Male | OS | 42 | No | Yes | Yes | No | 10.7 | |
14 | Male | OS | 62 | PRP | No | Yes | No | 8.3 | |
15 | Male | OD | 48 | PRP | No | No | Yes | 5.7 | |
16 | Female | OS | 61 | No | No | Yes | No | 5.3 | |
17 | Male | OS | 56 | No | Yes | Yes | No | 10.8 | |
18 | Male | OD | 63 | IVT | No | Yes | Yes | 6.3 | |
19 | Male | OD | 82 | No | Yes | No | Yes | 8.8 | |
20 | Female | OS | 58 | No | No | Yes | Yes | 10.7 |
Bold text: lost to follow-up; not included in analysis.
IVT, intravitreal triamcinolone; OD, right eye; OS, left eye; Prior Tx, grid, focal, panretinal laser photocoagulation, intravitreal triamcinolone; PRP, panretinal laser photocoagulation.